Totally implantable femoral vein catheters in cancer patients

European Journal of Surgical Oncology

Volumn 30, Issue 7, 2004, Pages 771-775

  Wolosker, N ^a,b   Yazbek, G ^a   Munia, M A ^a   Zerati, A E ^a   Langer, M ^a   Nishinari, K ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b NONE   (Brazil)

Author keywords

Catheter; Chemotherapy; Femoral vein; Infection; Obstruction; Thrombosis; Totally implantable venous access

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; BACTEREMIA; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DEVICE REMOVAL; DRUG DELIVERY SYSTEM; FEMORAL VEIN; HUMAN; IMPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAFETY; SKIN INFECTION; VASCULAR ACCESS; VEIN CATHETERIZATION; VEIN THROMBOSIS;

ADULT; AGED; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FEMALE; FEMORAL VEIN; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 4243152970     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.05.019     Document Type: Article

References (23)

1. Schwarz R.E. Groeger J.S. Coit D.G. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis Cancer 79 8 1997 1635-1640
2. Durbec O. Viviand X. Potie F. Vialet R. Albanese J. Martin C. A prospective evaluation of the use of femoral venous catheters in critically ill adults Crit Care Med 25 12 1997 1986-1989
3. Bertoglio S. DiSomma C. Meszaros P. Gipponi M. Cafiero F. Percivale P. Long-term femoral vein central venous access in cancer patients Eur J Surg Oncol 22 2 1996 162-165
4. Costantini R. Napolitano L. Scurti D. et al. Totally implantable central venous systems in neoplastic patients Ann Ital Chir 68 3 1997 357-360
5. Jaeger K. Osthaus A. Heine J. et al. Efficacy of a benzalkonium chloride-impregnated central venous catheter to prevent catheter-associated infection in cancer patients Chemotherapy 47 1 2001 50-55
6. Ranson M.R. Oppenheim B.A. Jackson A. et al. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients J Hosp Infect 15 1 1990 95-102
7. Minassian V.A. Sood A.K. Lowe P. et al. Longterm central venous access in gynecologic cancer patients J Am Coll Surg 191 4 2000 403-409
8. Ballarini C. Intra M. Pisani Ceretti A. et al. Complications of subcutaneous infusion port in the general oncology population Oncology 56 2 1999 97-102
9. Blot F. Nitenberg G. Chachaty E. et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures Lancet 354 9184 1999 1071-1077
10. Groebli Y. Bartolomei J. Wuthrich P. et al. Post-mortem evaluation following oncologic treatment of the functional and bacteriologic status of 25 permanent venous access devices Schweiz Med Wochenschr 128 36 1998 1334-1338
11. Raad I. Costerton W. Sabharwal U. et al. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement J Infect Dis 168 2 1993 400-407
12. Astagneau P. Maugat S. Tran-Minh T. et al. Long-term central venous catheter infection in HIV-infected and cancer patients: a multicenter cohort study Infect Control Hosp Epidemiol 20 7 1999 494-498
13. Kappers-Klunne M.C. Degener J.E. Stijnen T. et al. Complications from long-term indwelling central venous catheters in hematologic patients with special reference to infection Cancer 64 8 1989 1747-1752
14. Hanna H.A. Raad I. Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients Infect Control Hosp Epidemiol 22 3 2001 165-166
15. Balestreri L. De Cicco M. Matovic M. Central venous catheter-related thrombosis in clinically asymptomatic oncologic patients: a phlebographic study Eur J Radiol 20 2 1995 108-111
16. Gould J.R. Carloss H.W. Skinner W.L. Groshong catheter-associated subclavian venous thrombosis Am J Med 95 4 1993 419-423
17. Pintor Holguin E. Saez Noguero F. Piret Ceballos M.V. et al. Axillary-subclavian thrombosis: review of its etiology and features in recent Years An Med Interna 14 2 1997 67-70
18. De Cicco M. Matovic M. Balestreri L. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study Thromb Res 86 2 1997 101-113
19. Rodenhuis S. van't Hek L.G. Vlasveld L.T. et al. Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator Thorax 48 5 1993 558-559
20. Conlan M.G. Haire W.D. Lieberman R.P. et al. Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation Bone Marrow Transplant 7 3 1991 235-240
21. Monreal M. Davant E. Thrombotic complications of central venous catheters in cancer patients Acta Haematol 106 1-2 2001 69-72
22. Raad I.I. Luna M. Khalil S.A. et al. The relationship between the thrombotic and infectious complications of central venous catheters JAMA 271 13 1994 1014-1016
23. Ramacciotti E. Wolosker N. Puech-Leao P. Zeratti E.A. Gusson P.R. del Giglio A. Franco R.F. Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis Thromb Res 109 4 2003 171-174